$IART Balance Sheet | Understand Stock

$IART

$12.83 +$0.59 (4.82%) Close

$IART Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Sep 30, 2026	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Trade accounts receivable, net of allowances of $7,333 and $7,230
Inventories, net
Prepaid expenses and other current assets
Assets held for sale
Prepaid expenses
Other current assets
Total current assets

Property, plant and equipment, net
Right of use asset - operating leases
Intangible assets, net
Goodwill
Deferred tax assets, net
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of borrowings under senior credit facility
Short-term borrowings under securitization facility
Current portion of borrowings under securitization facility
Current portion of lease liability - operating leases
Convertible securities
Accounts payable, trade
Contract liabilities
Income tax payable
Accrued compensation
Accrued expenses and other current liabilities
Liabilities held for sale
Total current liabilities

Long-term borrowings under senior credit facility
Long-term borrowings under securitization facility
Long-term convertible securities
Lease liability - operating leases
Deferred tax liabilities
Other liabilities
Total liabilities
Stockholders’ equity:
Preferred stock; no par value; 15,000 authorized shares; none outstanding
Common stock; $0.01 par value; 240,000 authorized shares; 92,098 and 92,286 issued at September 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Treasury stock, at cost; 8,918 shares and 6,823 shares at March 31, 2023 and December 31, 2022, respectively
Treasury stock, at cost; 14,292 shares and 14,399 shares at September 30, 2026 and December 31, 2025, respectively
Accumulated other comprehensive loss
Retained earnings
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments